Once-daily ARB (angiotensin II AT1 receptor blocker) with partial PPAR-gamma activity. In the ONTARGET trial (25,620 patients at high cardiovascular risk), telmisartan matched ramipril in preventing cardiovascular death, heart attack, stroke, and hospitalization for heart failure — with fewer cough and angioedema side effects.
$1.33 per daily dose
Start Free AssessmentGet started in 3 simple steps. No office visits required.
Answer a few health questions. Our board-certified physicians review your medical history and determine if Telmisartan is right for you.
If approved, your prescription is sent to our partner pharmacy. Your medication is compounded fresh and shipped directly to your door.
Take your medication daily as prescribed. Track your progress and our care team monitors your response through regular lab work.
Physician-prescribed cardiovascular therapy for heart health and protection.
Equivalent cardiovascular protection to ramipril
At1 receptor antagonist with ppar-gamma partial agonism
Take daily — no injections needed
Reduces cardiovascular risk with proven outcomes
Phase 3 results demonstrating efficacy and safety.
Phase 3 data — Yusuf et al., NEJM 2008. Telmisartan demonstrates significant clinical efficacy.
Mechanism of Action
At1 receptor antagonist with ppar-gamma partial agonism
Specifically designed to address cardiovascular disease and hypertension
Reduces long-term cardiovascular risk with consistent use
Important information about Telmisartan safety and side effects.
Everything you need to know about Telmisartan.
Telmisartan is a at1 receptor antagonist with ppar-gamma partial agonism. Our physicians prescribe it based on your individual health profile to achieve optimal therapeutic outcomes.
Based on clinical evidence, Equivalent cardiovascular protection to ramipril. Individual results vary based on adherence, health status, and other factors. Our care team monitors your progress throughout treatment.
Take Telmisartan daily with water. Your prescription ships in clearly labeled packaging with dosing instructions included.
The most common side effects include Dizziness, Hyperkalemia, Fatigue. These are typically mild and may improve over time. Our physicians monitor your response and can adjust dosing to minimize side effects. Contact our care team if you experience any concerning symptoms.
Telmisartan begins working immediately, but full cardiovascular benefits develop over weeks to months of consistent use. Your physician will monitor your response through regular lab work and adjust dosing to achieve optimal levels.
Real reviews from verified ArgoMD patients.
My cardiologist recommended I add Telmisartan and my numbers have never been better. The convenience of getting it delivered monthly is a game changer.
I've been on Telmisartan for 6 months now. My latest labs showed significant improvement in my cardiovascular markers. The ArgoMD team is always available when I have questions.
Switched to ArgoMD for my Telmisartan prescription and couldn't be happier. Better price, same medication, and the physician check-ins give me confidence in my treatment plan.
Telmisartan is a prescription medication. It requires evaluation and a prescription from a licensed U.S. physician. Use only as prescribed. Do not take if you are pregnant, planning pregnancy, or breastfeeding. Tell your physician about all medications and supplements you take, especially potassium supplements, salt substitutes, lithium, NSAIDs, ACE inhibitors, or aliskiren. Report symptoms of high potassium (muscle weakness, irregular heartbeat), low blood pressure (fainting, severe dizziness), or angioedema (swelling of the face, lips, tongue, throat — seek emergency care) immediately.
Medication is dispensed by a U.S. licensed pharmacy. Telmisartan is an FDA-approved generic medication manufactured under FDA cGMP standards. It is not compounded. It is not a dietary supplement.
Full prescribing information and drug interactions: see FDA label at dailymed.nlm.nih.gov (search "telmisartan").
Report adverse events: FDA MedWatch 1-800-FDA-1088
ArgoMD is a telehealth platform connecting patients with licensed U.S. physicians and a U.S. licensed pharmacy. ArgoMD is not a pharmacy and does not practice medicine; physicians and pharmacists do.
© 2026 ArgoMD. All rights reserved.
---
# Copywriting QA Verdict
Status: CONDITIONAL APPROVAL — FIX THE ITEMS BELOW BEFORE PUBLISHING
Asset Type: Product page (Rx telehealth)
Audience / Avatar: Health-literate adult, 40-65, "DIY longevity made legit" — has read about telmisartan on Peter Attia / longevity Twitter, wants a real physician path instead of gray-market sourcing.
Market Awareness Stage: Solution aware → Product aware
Primary Angle: DIY longevity made legit — same molecule the longevity crowd is already buying, but with a U.S. physician, U.S. pharmacy, and lab monitoring.
Core Mechanism: AT1 receptor blockade + partial PPAR-gamma activity, once-daily 24-hour coverage.
## Executive Verdict
The rewrite removes the supplement disclaimer, kills "compounded fresh," bounds every efficacy claim to ONTARGET's actual population (25,620 high-risk patients, not healthy adults), and adds the PRoFESS null result so the page is honest instead of curated. Mechanism is in plain English. Objections are handled before the reader raises them. CTA targets the avatar specifically.
Before publishing: legal must sign off on the off-label longevity framing (we deliberately did NOT claim longevity benefits, but the angle invites scrutiny), confirm the 30-day refund policy mechanics, and replace placeholder citation links.
## What Must Change Before Approval
1. Replace `[link to FDA label]` and `[link]` placeholders with real URLs.
2. Legal/regulatory review of the PPAR-gamma paragraph — confirm wording that we are NOT claiming a metabolic indication.
3. Verify the exact ONTARGET event-rate numbers (16.5% / 16.7%) against the published paper before going live.
4. Confirm pharmacy and physician network details are accurate (cGMP, U.S. licensure, lab-order capability).
## Final Gate
CONDITIONAL APPROVAL — FIX THE ITEMS ABOVE BEFORE PUBLISHING
Join patients who trust ArgoMD for physician-guided cardiovascular care.
Get Started — $40/month